Anthem awaiting more Aduhelm data before deciding coverage

Anthem will further evaluate Aduhelm before it announces whether or not the Alzheimer's drug will be covered, Yahoo News reported. 

The news came July 21 during the insurer's second-quarter earnings call.

Anthem joins UnitedHealth in waiting to cover the drug since its FDA approval, while a handful of Blue Cross Blue Shield affiliates have declined to cover it.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Top 40 articles from the past 6 months